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First case of Salmonella hirschfeldii (paratyphi C) 
infection of a prosthetic hip 
Clin Microbiol Infect 1998; 4: 228-230 
Infection after a total hip replacement is a serious 
complication, ohen requiring removal of the prosthesis 
for healing [l]. The commonest etiologic agents are 
Staphylococcus aureus and Staphylococcus epidermidis, which 
account for more than 50% of the pathogens isolated, 
according to recent series. Other organisms may be 
involved, especially in hematogenous infections, in- 
cluding Gram-negative bacteria, Streptococcus, anaerobic 
bacteria, chphtheroids, or mycobacteria [1,2]. We report 
the first case of typhoid salmonella infection of a total 
hip prosthesis. 
A 51-year-old black African man was admitted 
because of fever, pain of the right hip and a fistula from 
the joint to the thigh surface. His past medical history 
was remarkable for several episodes of malaria, and type 
2 diabetes meultus. Eleven years before this admission, 
he suffered post-traumatic necrosis of the right femoral 
head, and underwent total hip arthroplasty with a 
satisfactory postsurgical functional result. Thirty months 
before admission, the patient suddenly developed a 
fever, and swelling of the upper lateral part of the 
right thigh. A hlp puncture, performed in Brazzaville, 
Concise C o m m u n i c a t i o n s  229 
Congo, withdrew 1.5 L of a purulent fluid. He sub- 
sequently developed a chronic fistula with a purulent 
discharge at the puncture site. Many prolonged anti- 
infectious regimens were prescribed there, including 
co-trimoxazole, amoxicdhn, and chloramphenicol, but 
the patient's general status and local symptoms pro- 
gressively deteriorated. He was transferred to our 
department. 
On adrmssion, his body temperature was 38.5"C. 
Movement of the right hip was painfll, limited to 20° 
of flexion, and 10" of abduction. The discharge &om 
the fistula was yellowish-green, and the surrounding 
skin was erythematous. Laboratory values were as 
follows: white blood cell (WBC) count 4800/mm3 
with a normal differential; hemoglobin 12 g/& with 
a mean corpuscular volume of 74 pm3. Hemoglobin 
electrophoresis revealed a heterozygous state for sickle 
cell disease. Serology was positive for HIV-1 by ELISA, 
and confirmed by Western blot. CD4 T-cell count was 
1000 cells/mm3. Glycemia was 16.7 mmol/L. Hip X- 
ray revealed migration of the acetabulum and lysis of 
the femoral metaphysis. Bacteriologic culture of the 
fistula discharge yielded Salmonella hirschfeldii (formerly 
paratyph C).  Blood culture remained sterile. Stool 
cultures were negative. 
The hip prosthesis was removed, associated with a 
complete cement extraction, a thorough debridement, 
and drainage of the voluminous purulent abscess of 
the vastus externus through which the fistula joined 
the hip joint. Intraoperative samples of bone, cement, 
prosthesis and pus also yielded Salmonella hirschjefdii. 
Traction of the hip was maintained for 6 weeks. 
Ofloxacin (200 mg b.i.d. per 0s) was prescribed for 3 
months. The pathogen isolated was highly sensitive 
to thls antibiotic, with MIC and MBC at 0.125 and 
0.25 mg/L respectively. The patient became afebrile 
and has remained so during the 12 months of follow- 
up. Hip mobility improved and is now 50° of flexion, 
and 30" of abduction. 
Salmonellae are non-spore-forming Gram-negative 
rods of the f a d y  Enterobacteriaceae. Although non- 
typhoid salmonellae are primary pathogens of lower 
animals, typhoid salmonellae have reservoirs primarily 
in humans. Thus, direct or indirect contact with a 
person with typhoid fever or with a chronic carrier is 
necessary for infection. There has been an impressive 
decline in the number of cases of typhoid fever in 
developed countries since 1900 in conjunction with 
improved sanitation [3]; and as total hip replacements 
are mostly performed in these countries, there is little 
chance of observing typhoid salmonella infection of a 
hip prosthesis. However, typhoid salmonellae have not 
chappeared in developed countries, and primary septic 
arthritis of the hip due to Salmonella paratyphi B in a 
diabetic Caucasian woman has been reported in the 
Many studes have demonstrated a high percentage 
of underlying disease in patients with salmonella 
infections. Patients with sickle cell diseases have an 
increased incidence of serious bacteremic infection and 
osteomyelitis with salmonellae for various reasons: (1) 
their alternative complement pathway is defective [5]; 
(2) erythrophagocytosis impairs the phagocytosis of 
salmonellae by monocytes [6]; and (3) splenic in- 
farctions lead to functional splenectomy. Furthermore, 
it has been demonstrated that hemolysis induced 
experimentally in mice markedly enhanced suscepti- 
bility to infection with Salmonella typhimurium [7]. 
Our patient presented two other conditions that may 
have facilitated the development of salmonellosis: (1) 
HIV infection and (2) seriously uncontrolled diabetes 
mellitus. One small study performed in an endemic 
area estimated the incidence of typhoid salmonella 
infection in HIV-infected patients to be 60 times that 
of the general population [8]. The severity of typhoid 
salmonella infections in HIV-infected patients without 
AIDS is similar to that of infection in immuno- 
competent hosts [3]. Diabetic patients are not con- 
sidered to be at risk for salmonellosis, but they have a 
preddection for certain infections (e.g. pseudomonas 
'malignant' external otitis, monilial skin infections, 
rhinocerebral mucormycosis) [9], and our patient's 
diabetes may have contributed to the development 
of salmonellosis, in combination with his other risk 
factors. 
Given the known pathophysiology of typhoid 
salmonellae [3] ,  we presume that the infection occurred 
via the hematogenous route. Our patient gave no 
history of fever or enteric symptoms preceding the 
onset of the symptoms, and we have no argument for 
a gastrointestinal pathology that could have increased 
susceptibility to salmonellosis. However, neither barium 
X-ray studies nor digestive endoscopy were performed, 
which might have revealed an asymptomatic lesion. He 
is probably not a chronic carrier, because the stool 
cultures performed in our department did not yield any 
salmonellae, and he has not relapsed since. 
Prognostic factors of prosthetic joint infections 
are not clearly established, but are probably strongly 
associated with early, extensive and meticulous surgical 
debridement, effective antimicrobial therapy, and the 
immune status ofthe patient [lo]. The delayed initiation 
of treatment for our patient and his immune status 
are probably more important prognostic factors than 
the nature of the pathogen involved. To the best of our 
knowledge, there is no reported case of typhoid 
salmonella infection of a joint prosthesis. Samra et al 
reported five cases of non-typhoid salmonellosis in 
IJK ~41. 
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patients with total hip replacement, and found five 
more cases by reviewing the Enghsh literature [ll]. All 
their patients recovered, as did four of the five patients 
reported in the literature (the fifth was continuing 
therapy at the time of the report). The overall prognosis 
of salmonella infection does not seem to d&er from 
that of the overall prognosis of prosthetic joint in- 
fection. In the case we describe, because the surgical 
intervention was extensive, the anti-infectious regimen 
well adapted according to in vitro studies, and no relapse 
has occurred after 1 year without any antimicrobial 
therapy, treatment may be considered successful. Re- 
implantation of a total hip prosthesis can be reasonably 
performed, as soon as the patient so desires. 
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Successful treatment of Salmonella aortitis with 
ciprofloxacin 
Clin Microbiol Infect 1998; 4: 230-231 
Infectious aortitis is a not infrequent complication of 
salmonella bacteremia, especially in the elderly and in 
patients with immunodeficiency syndromes. Despite 
the recommended aggressive management, which in- 
cludes appropriate antibiotics and prompt corrective 
surgery mortality rates of up to 50% are reported [l]. 
Medically treated patients usually die. We describe 
the first case of long-term suppression of an infected 
pseudoaneurysm of the abdominal aorta in the presence 
of a previous graft with ciprofloxacin alone. 
An 82-year-old female patient with a history of 
cholecystectomy, who had had an aortic grafi replace- 
ment for inkarenal aneurysm in 1984, was admitted for 
acute abdominal pain with nausea in May 1995. She 
reported a history of mild gastroenteritis followed by 
anorexia and weight loss, and had had shoulder and 
back pain for the previous month, though without a 
temperature. One week before, she had been started on 
8. Gotuzzo E, Frisancho 0, Liendo G, et al. Association 
infection with Salmonella typhi or Salmonella paratyphi in an 
Figure 1 CT scan shows an i h r e n a l  aorta of normal size 
tissue 
between the acquired-imunodeficien~ and proximal the graft anastomosis a p i a o r t i c  soft 
( 0 ) .  
